Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

@article{Masaki2016ProposedDC,
  title={Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.},
  author={Yasufumi Masaki and Hiroshi Kawabata and Kazue Takai and Masaru Kojima and Norifumi Tsukamoto and Yasuhito Ishigaki and Nozomu Kurose and Makoto Ide and Jun Murakami and Kenji Hatano Nara and Hiroshi Yamamoto and Yoko Ozawa and H Takahashi and Katsuhiro Miura and Tsutomu Miyauchi and Shinichirou Yoshida and Akihito Momoi and Nobuyasu Awano and Soichiro Ikushima and Y Ohta and Natsue Furuta and Shino Fujimoto and Haruka Kawanami and Tomoyuki Sakai and Takafumi Kawanami and Yoshimasa Fujita and Toshihiro Fukushima and Shigeo Nakamura and Tomohiro Kinoshita and Sadao Aoki},
  journal={International journal of hematology},
  year={2016},
  volume={103 6},
  pages={686-92}
}
TAFRO syndrome is a systemic inflammatory disorder characterized by thrombocytopenia, anasarca including pleural effusion and ascites, fever, renal insufficiency, and organomegaly including hepatosplenomegaly and lymphadenopathy. Its onset may be acute or sub-acute, but its etiology is undetermined. Although several clinical and pathological characteristics of TAFRO syndrome resemble those of multicentric Castleman disease (MCD), other specific features can differentiate between them. Some… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
30 Citations
17 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Similar Papers

Loading similar papers…